The role of implanted antitachycardia devices is expected to expand, though socioeconomic impacts and the need for further efficacy studies remain challenges.
May support expanded antitachycardia device use pending data; leaves open socioeconomic impacts and efficacy validation.
With the limitations of currently available modalities for treating clinically important tachycardias, the role of implanted antitachycardia devices will continue to expand. The challenge of the future will not only involve continued technological advances but the socioeconomic impact of this efficacious but expensive mode of therapy in an era of increasing financial restraints. Further studies to definitively prove the efficacy of more widespread use of antitachycardia device therapy will be needed.
No takes yet. Share an insight, caveat, or question.
Rosenthal et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: